Overall, alterations in EGFR and ALK genes are relatively rare in primary PLEC However, there may still be some special cases with EGFR or ALK gene alterations that interact with other factors or are related to individual differences of patients, tumor heterogeneity, or detective methods (65). This evidence concerns the gene EGFR and neoplasm.